Clinical Trial Update: Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer [NA]

View source ↗

Summary

A clinical trial evaluating daily online adaptive short-course radiation therapy with concurrent chemotherapy for muscle-invasive bladder cancer sponsored by Va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Muscle Invasive Bladder Urothelial Carcinoma | NA | Status: TERMINATED